# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The Benzinga Stock Whisper highlights five stocks weekly that are seeing increased interest from readers.
Raymond James analyst Steven Seedhouse upgrades Viking Therapeutics (NASDAQ:VKTX) from Outperform to Strong Buy and raises t...
Truist Securities analyst Joon Lee reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $120 price target.